Nkarta Therapeutics CEO, Paul Hastings, Named BIO Chair for 2021-2022 Term
June 14, 2021 07:01 ET
|
Nkarta, Inc.
SOUTH SAN FRANCISCO, Calif., June 14, 2021 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer,...
Prospekt Juni 2021
June 14, 2021 07:00 ET
|
Investeringsforeningen Great Dane
Investeringsforeningen Great Dane har offentliggjort opdateret prospekt for foreningen. Prospektet er opdateret med nye bestyrelsesmedlemmer. Opdateret prospekt kan findes på foreningens...
Yumanity Therapeutics Appoints Devin W. Smith as General Counsel
June 14, 2021 07:00 ET
|
Yumanity Therapeutics Inc
BOSTON, June 14, 2021 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying...
Allarity Therapeutics and Oncoheroes Biosciences to Partner on Pediatric Cancer Development of Dovitinib and Stenoparib
June 14, 2021 07:00 ET
|
Allarity Therapeutics A/S
Oncoheroes will fund and advance clinical development of both dovitinib and stenoparib in pediatric cancersAllarity is preparing to file a first U.S. new drug application (NDA) for the approval...
ADMA Biologics to Participate in the Raymond James Human Health Innovation Virtual Conference
June 14, 2021 07:00 ET
|
ADMA Biologics, Inc.
RAMSEY, N.J. and BOCA RATON, Fla., June 14, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (the “Company”), an end-to-end commercial biopharmaceutical company dedicated to...
Coro Global Democratizing Gold In Tennessee - Reaches The 31st U.S. License Milestone
June 14, 2021 07:00 ET
|
Coro Global Inc.
Miami, June 14, 2021 (GLOBE NEWSWIRE) -- Coro Global Inc. (OTCQB: CGLO) announced today that its subsidiary Coro Corp., was granted a U.S. Money Transmitter license by the State of Tennessee. ...
REPEAT – MEDIA ADVISORY: Ontarians virtually “Pack the Galleries” to protect democracy
June 14, 2021 07:00 ET
|
Ontario Federation of Labour
TORONTO, June 14, 2021 (GLOBE NEWSWIRE) -- Ontarians are outraged that Ford is recalling the legislature to use the notwithstanding clause to override the constitution, after a judge ruled key parts...
GBT’s Voxelotor is First Sickle Cell Disease Treatment to Receive Promising Innovative Medicine (PIM) Designation in the UK
June 14, 2021 07:00 ET
|
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif. and LONDON, June 14, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT), a biopharmaceutical company dedicated to the discovery, development and...
Opthea Appoints Company Secretary and Vice President of Finance
June 14, 2021 07:00 ET
|
Opthea Limited
MELBOURNE, Australia, June 14, 2021 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; Nasdaq:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and...
G1 Therapeutics Initiates PRESERVE 3, A Randomized Phase 2 Study of COSELA™ (trilaciclib) in Bladder Cancer
June 14, 2021 07:00 ET
|
G1 Therapeutics
RESEARCH TRIANGLE PARK, N.C., June 14, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the Company has initiated PRESERVE 3,...